,Gene_Symbol,Drugs,Drugs_Action,Phenotype_Safety,Phenotype_Essentiality,Drugs_Group,Gene_Categories,ATC_Code,Gene_Categories.1,Drugs_Categories,side_effect_name,Meddra_Indication,Antiviral_Species
Methotrexate,DHFR,Methotrexate,inhibitor,1.0,1.0,approved|investigational,target,L01BA04,target,"Amino Acids|Amino Acids, Acidic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins|Antimetabolites|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Substrates|Drugs that are Mainly Renally Excreted|Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index|Enzyme Inhibitors|Folic Acid Analogues|Folic Acid Antagonists|Glutamates|Heterocyclic Compounds, Fused-Ring|Immunosuppressive Agents|Myelosuppressive Agents|Nucleic Acid Synthesis Inhibitors|OAT3/SLC22A8 Substrates|Purines|Purinones",,"['Breast cancer', 'Mesothelioma', 'Non-small cell lung cancer', 'Pleural mesothelioma malignant']",0
Methotrexate,TYMS,Methotrexate,substrate,1.0,1.0,approved,enzyme,L01BC52|L01BC02,enzyme,Antimetabolites|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P-450 Substrates|Fluoropyrimidines|Fluorouracil and prodrugs|Immunologic Factors|Immunosuppressive Agents|Misc. Skin and Mucous Membrane Agents|Moderate Risk QTc-Prolonging Agents|Myelosuppressive Agents|Noxae|Nucleic Acid Synthesis Inhibitors|Nucleoside Metabolic Inhibitor|Pyrimidine Analogues|Pyrimidines|Pyrimidinones|QTc Prolonging Agents|Thyroxine-binding globulin inducers|Toxic Actions,"['Cardiotoxicity', 'Ocular toxicity']","['Actinic keratosis', 'Basal cell carcinoma', ""Bowen's disease"", 'Cervix carcinoma', 'Colon cancer', 'Dihydropyrimidine dehydrogenase deficiency', 'Hyperkeratosis', 'Neoplasm malignant', 'Oesophageal carcinoma', 'Renal cell carcinoma', 'Seborrhoeic keratosis', 'Skin cancer']",0
Sofosbuvir,CMPK1,Sofosbuvir,substrate,3.0,4.0,approved,enzyme,J05AP08|J05AP51|J05AP55|J05AP56,enzyme,"Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Antivirals for treatment of HCV infections|BCRP/ABCG2 Substrates|Carbohydrates|Direct Acting Antivirals|Drugs that are Mainly Renally Excreted|Glycosides|Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Nucleotides|P-glycoprotein substrates|Pyrimidine Nucleosides|Pyrimidine Nucleotides|Pyrimidines|Ribonucleosides|Ribonucleotides|RNA Replicase Inhibitors|Uracil Nucleotides",,"['Chronic hepatitis C', 'Hepatitis C', 'Mental disorder']",HCV; CHIKV; ZIKV
Valaciclovir,GUK1,Valaciclovir,substrate,3.0,16.0,approved|investigational,enzyme,J05AB11,enzyme,"Acyclovir and prodrug|Amino Acids|Amino Acids, Branched-Chain|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Direct Acting Antivirals|Drugs that are Mainly Renally Excreted|Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor|Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor|Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor|Heterocyclic Compounds, Fused-Ring|Nephrotoxic agents|Nucleic Acid Synthesis Inhibitors|Nucleosides and Nucleotides|Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors|OAT3/SLC22A8 Substrates|Prodrugs|Purines|Purinones",,"['Congenital herpes simplex infection', 'Dermatitis', 'Genital herpes', 'Herpes simplex', 'Herpes virus infection', 'Herpes zoster', 'Herpes zoster disseminated', 'Immunodeficiency', 'Infection', 'Ophthalmic herpes zoster', 'Opportunistic infection', 'Oral herpes', 'Pain', 'Papule', 'Post herpetic neuralgia', 'Rash', 'Renal failure', 'Renal impairment', 'Sexually transmitted disease', 'Transplant rejection', 'Ulcer', 'Varicella']",HSV; CMV; EBV; HBV; HSV-1; HSV-2; VZV
